張 璽

Medicine & Life Sciences

1. Seizures 100%
2. Induced Pluripotent Stem Cells 93%
3. Pentylenetetrazole 78%
4. Skeletal Muscle 71%
5. Muscles 68%
6. Child 64%
7. Muscle Cells 48%
8. Atrophic Muscular Disorders 48%
9. Transcription Factor AP-1 45%
10. Status Epilepticus 41%
11. Stem Cells 37%
12. Ganoderma 33%
13. Atrophy 33%
14. Atypical Teratoid Tumor 32%
15. Muscular Atrophy 32%
16. Parvalbumins 31%
17. Drug Therapy 31%
18. Transplantation 31%
19. Bone Marrow 30%
20. Glycogen Storage Disease Type II 29%
21. Green Fluorescent Proteins 29%
22. Brain Neoplasms 29%
23. Taiwan 29%
24. Population 28%
25. Cell Proliferation 28%
26. Exposure to Violence 28%
27. Electrocorticography 28%
28. Lasers 28%
29. Multipotent Stem Cells 28%
30. Leukotriene Antagonists 27%
31. Craniopharyngioma 27%
32. Hemophagocytic Lymphohistiocytosis 27%
33. Tourette Syndrome 26%
34. Febrile Seizures 26%
35. Adrenal Insufficiency 26%
36. Sarcopenia 25%
37. Mouse Embryonic Stem Cells 25%
38. Leukotrienes 25%
39. Burkitt Lymphoma 24%
40. Neurologic Manifestations 24%
41. Neuromuscular Junction 24%
42. Paraplegia 23%
43. Embryonic Stem Cells 23%
44. Hippocampus 23%
45. Valproic Acid 22%
46. Cell Transplantation 22%
47. Precision Medicine 22%
48. Pediatrics 21%
49. Erotica 21%